The World OTC Medicine Market Report 2013

204 pages report Published in
Pharmaceuticals
Publisher: Espicom Limited

arrowFor This Report

Covering 72 country markets, worldwide, this new report is today’s essential business resource for all pharmaceutical executives with an interest in the global OTC medicine market!With the increasing availability of OTC medicines through non-pharmacist channels (supermarkets, petrol stations, kiosks etc) plus the global population’s enhancing knowledge of health awareness, the OTC medicines market is one of steady expansion and this equates to more opportunities for profit.

However, this is a market that cannot be entered into unprepared. Manufacturers can face increased distribution and marketing costs and the lack of OTC medicine definition (particularly in emerging and frontier markets) can make market size and operating landscapes unclear. This is where The World OTC Medicine Market Report 2013 can help.

Key Market Questions Answered by The World OTC Medicine Market Report 2013:

  • Which country has the highest OTC medicine expenditure?
  • Which Latin American country is forecast to have the strongest growth?
  • What are the over-the-counter (OTC) market indicators the US?
  • How does the Brazilian market compare with China, Russia and India, historically?
  • What are the key trends affecting the Middle East & Africa countries?

The World OTC Medicine Market Report 2013 is the foolproof business resource for any industry executive in today’s challenging global market environment. The need for hard facts and statistics to back up everyday business decisions is essential and it is this report that can provide you with the answers.

With hundreds of comparable data points available, who else will provide you with:

  • Our exclusive analysts’ industry opinion – not found anywhere else!
  • Key historical data and industry forecasts (2009 – 2017) for 72 countries worldwide
  • Over-the-counter (OTC) medicine market indicators
  • Detailed tables and representative graphs with key comparisons such as the top 30 markets by value and by per-capita spending

Table of Contents


BMI Industry View 11


Industry Forecast 16

Africa 16

Algeria 17

Table: Algeria Over- The-Counter (OTC) Medicine Market Indicators, Historical Data and forecasts 18

Egypt 19

Table: Egypt Over-The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts 20

Ghana 21

Table: OTC Medicine Sales, 2009-2017 22

Kenya 23

Table: Kenya OTC Medicine Marker Indicators, Historical Data and Forecasts 24

Morocco 25

Table: Morocco Over- The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts 26

Nigeria 27

Table: Nigeria Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts 28

South Africa 29

Table: South Africa Over- The-Counter (07C) Medicine Market Indicators, Historical Data And Forecasts 30


Industry Forecast 31

Asia Pacific

Australia 32

Table: OTC Medicine Sales, 2009-2017 32

Bangladesh 33

Table: Bangladesh Over- The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts U

China

Regulatory Regime 36

Table: OTC Medicine Sales Indicators 2009-2017 38

Hong Kong 39

Table: OTC Medicine Sales Indicators, 2009-2017 41

India 42

Table: OTC Medicine Sales, 2009-2017 43

Indonesia 44

Table: Indonesia Over-The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts 45

Table: Table: OTC Medicine Sales By Category, 2006-2010 46

Japan 47

Table: OTC Medicine Market Indicators, Historical Data and Forecasts 50

Malaysia 51

Table: OTC Medicine Sales indicators 2009-2017 52

New Zealand 53

Table: .New Zealand Over- The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts 53

Pakistan 54

Table: Pakistan Over-The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts 55

Philippines 56

Table: Philippines Over- The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts, 2009-2017 57

Singapore 58

Table: OTC Medicine Sales Indicators, 2009-2017 59

South Korea 60

Table: Last Of OTC Drugs to Be Sold Outside pharmacies 60

Table: South Korea Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts 63

Taiwan 64

Table: Taiwan Over-The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts 66

Thailand 67

Table: Thailand Over-The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts 68

Table: OTC Medicine Sales Indicators by Category. 2006-2008 68

Vietnam 69

Table: OTC Medic Inc Sales Indicators, 2009-2017 71


Industry Forecast 72

Europe 72

Belarus 73

Table: Table: Belarus Over-The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts, 2009-2017 75

Belgium 76

Table: Belgium Over-The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts 77

Bulgaria 78

Table: Bulgaria Over-The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts 79

Table: Top Ten Non-Prescription Drugs By Volume, 2009 80

Table: Top Ten Non-Prescription Drugs By Value, 2009 80

Croatia 81

Table: Croatia Over-The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts, 2009-2018 82

Czech Republic 83

Table: Czech Over-The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts 85

Estonia 86

Table: Estonia Over-The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts, 2009-2017 87

France 88

Table: France Over- The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts 90

Germany 91

Table: Germany Over The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts 92

Greece 93

Table: OTC Medicine Sales, 2009-2017 94

Table: OTC Medicine Sales Breakdown, 2007-2010 94

Hungary 95

Table: Hungary Over-The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts 97

Table: OTC Medicine Sales Sub-Indicators, 2005-2010 98

Italy 99

Table: Italy Over- The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts 100

Kazakhstan 101

Table: Kazakhstan over The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts, 2009-2017 102

Latvia 103

Table: Latvia Over- The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts 104

Lithuania 105

Table: Lithuania Over-The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts 106

Moldova l07

Table: Moldova Over-The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts 108

Netherlands 109

Table: Table: Netherlands Over- The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts 111

Table: Table: OTC Medicine Sales Indicators By Category. 2008-2010 112

Poland 113

Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts, 2009-2017 114

Portugal 115

Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts 117

Table: OTC Sales Outside Of Pharmacies By Therapeutic Group (Jan-Sep 2012) 117

Table: OTC Sales Outside Of Pharmacies By District (Jan-Sep 2012) 116

Table: OTC Sales Outside Of Pharmacies By Sales Outlet (Jan-Sep2Ol2) 118

Table: Portugal OTC Sales Outside Of Pharmacies By Active Ingredient (Jan-Sep 2012) 119

Romania 120

Table: OTC Medicine Sales By Subsector, 2007-2010 122

Table: Rumania Over- The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts, 2009-2017 123

Russia 124

Table: Russia Over- The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts 126

Serbia 127

Table: Serbia Over- The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts 128

Slovakia 129

Table: Leading Prescription Medicines In Slovakia, By 2011 Volume 130

Table: Over-The-Counter (OTC) Medicine Market Indicators Historical Data And Forecasts 131

Table: OTC Medicine Sales Breakdown, 2004-2009 131

Slovenia 132

Table: Slovenia Over-The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts 133

Spain 134

Table: Spain OTC Medicine Market Indicators, Historical Data And Forecasts 135

Sweden 136

Table: Table: OTC Sales By Therapeutic Group At Retail Prices, 2009-2010 (SEKmn) 138

Table: Table: Leading OTC Drugs At Retail Prices, 2009-2010 (SEKmn) 138

Table: Swede,, Over- The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts 139

Switzerland 140

Table: OTC Medicine Market Indicators, Historical Data and Forecasts 141

Turkey 142

Table: Turkey Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts 143

UK 144

Table: OTC Sales hr Therapeutic Category at Retail Prices, 2008-11 (GBPmn) 145

Table: UK Over-The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts 148

Table: Medicine Sales Breakdown, 2005-2010 /48

Ukraine 149

Table: OTC Medicine Market Indicators, Historical Data and Forecasts 150

Uzbekistan 151

Table: Uzbekistan Over-The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts 152


Industry Forecast 153

Latin America 153

Argentina 154

Table: Argentina Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts 155

Brazil 156

Table: Brazil Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts 157

Chile 158

Table: Chile Over- The-Counter (OTC) Medicine Market Indicators, Historical Data & Forecasts, 2009-2011 1St'

Colombia 160

Table: Colombia Over- The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts 162

Mexico 163

Table: OTC Medicine Sales Indicators 2009-20)7 165

Peru 166

Table: OTC Medicine Sales Indicators 2006-2016 167

Venezuela 168

Table: OTC Medicine Sales, 2009-2017 169


Industry Forecast 170

Middle East 170

Bahrain 171

Table: Bahrain Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts 172

Iran 173

Israel 174

Table: Israel Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts 175

Jordan 176

Table: Jordan Over-The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts 177

Kuwait 178

Table: OTC Medicine Sales Indicators, 2009-20)7 180

Lebanon 181

Table: Lebanon Over- The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts, 2009-2017 182

Oman 183

Table: Oman Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts, 2009-2017 184

Qatar 185

Table: Qatar Over- The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts 186

Saudi Arabia 187

Table: Saudi Arabia Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts 188

UAE 189

Table: OTC Medicine Sales Indicators, 2009-2017 190


Industry Forecast 191

North America 191

Canada 192

Table: Over-The-counter (OTC) Medicine Market Indicators, Historical Data And Forecasts 193

US 194

Table: US Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts 196


Glossary 197


Methodology 199

Pharmaceutical Expenditure Forecast Model 199

Healthcare Expenditure Forecast Model 199

Notes On Methodology 200

Risk/Reward Ratings Methodology 201

Ratings Over view 202

Table: Pharmaceutical Risk/Reward Ratings Indicators 202

Indicator Weightings 203


Related Reports

  • The World Prescription Drug Market ReportThe back-lash of the 2007/2008 global financial crisis led to pressure from governments reducing healthcare budgets. This, in turn, left the global prescription market feeling the pinch. But with the global population ageing, the rise of chronic illnesses and universal healthcare schemes being unveiled worldwide, the prescription drug market has the opportunity for growth - but in what countries? Key Market Questions Answered by The World Prescription Drug Market Report: Which […]
  • Peripheral Vascular Devices – Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018Global Market Watch: BRICSS Peripheral Vascular Devices sector forecasts to reach at US$732 million by 2016. China accounts for highest percentage approximately 34% (2015) and India follows next with nearly 25% (2018) of the market share. BRICSS projections for Peripheral Vascular Stents market share indicate nearly 36% by 2015 leaving the rest of the market to the Vascular Closure Devices, AAA Stent Grafts, Inferior Vena Cava (IVC) Filters)…etc. Vascular Closure Devices market […]
  • Inferior Vena Cava (IVC) Filters – Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018Global Market Watch: BRICSS IVC Filter Devices market value is expected to reach US$71 million by 2016, primarily supported by the product types - Retrievable Filters and Permanent IVC Filters. China accounts for nearly 33% of the market share and India claims more than 24%. In terms of CAGR, China is the fastest growing region while India and Russia are just behind. Among the product types, Retrievable IVC Filters market value indicates more than 60% by 2015 leaving the rest of […]
  • Cardiac Defibrillators – Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018Global Market Watch: BRICSS Cardiac Defibrillators market value is expected to reach US$1.5 billion by 2016, primarily supported by the product types - Implantable Cardioverter Defibrillators (ICD) and External Defibrillating Devices. China accounts for nearly 27.4% of the market share and India claims more than 23.8%. In terms of CAGR, China is the fastest growing region while India and South Korea are just behind. Among the product types, Implantable Cardioverter Defibrillators […]
  • Zimbabwe Pharmaceuticals and Healthcare Report Q1 2015BMI View: The World Health Organization's approval of a quality control laboratory for medicines in Zimbabwe is a positive step for the country's pharmaceutical market. It will help to reduce the proportion of counterfeit medicines in circulation and increase the country's attractiveness to multinational drugmakers. Nevertheless, for the foreseeable future the dire economic and political outlook, reduced healthcare budget and underdeveloped local manufacturing industry will […]